Europe's over-the-counter (OTC) pharmaceuticals market size was valued at $26125 Mn in 2022 and is estimated to expand at a CAGR of 4.28% from 2022 to 2030 and will reach $36531.2 Mn in 2030. OTC are non-prescription medications and are a vital component of the healthcare system, offering consumers accessible solutions for a wide range of common health issues. The market is segmented by product type and distribution channel. The key market players are Johnson and Johnson Services Inc (USA), Bayer AG (Germany), Novartis AG (Switzerland) and others.
The EU telemedicine market is projected to grow $11.55 Bn in 2022 to $40.39 Bn in 2030 with a CAGR of 16.94% for the year 2022-2030. Increasing remote patient monitoring and technological innovations are major market drivers for the market in Europe. The market is segmented by type, clinical service, mode of delivery, and by region.